Type | Scaffold material | State of surface of scaffold | Coating on scaffold | Drug in coating | Example (Commercial name) |
Durable non-drug- eluting bare metal stent (BMS) | Durable metal | Plain | None | None |
|
| --Co-Cr --316 stainlesssteel --Pt-Cr --Nitinol |
|
|
| Driver MP35N Omega |
Durablenon-drug-eluting coated metal stent (CMS-I) | Durable metal | Plain | Yes Diamond-like coating or IrO, or TiN, or SiC coating | None | Titan |
Durable antigen/ inhibitor-eluting coated metalstent (CMS-II) | Durable metal | Plain | Yes | Yes, butdrug is a non-pharmacological agent |
|
|
|
| A polysaccharide matrix that contains anti-human CD34 antigen |
| Genous |
Durable drug-eluting bare stent (DES-I) | Durable metal | Microporous/textured | None | Yes |
|
| --stainless steel
--stainless steel |
Textured only on abluminal surfaces |
| Sirolimus
Biolimus A9 | Yukon
BioFreedom |
|
| Laser-cut Reservoirs partially filled with a drug and PLGA |
| Siromilus | NEVO
|
|
| Carbon-coated; Then deep abluminal reservoirs cutalong the struts and filled with a drug |
|
| Janus Flex (tater known as Optima) |
Durable early-and new-generation polymer-coated stent (DES-II) | Durable metal | Plain | Durable polymer | Yes |
|
| --Co-Cr --Co-Cr --Pt-Cr |
| PBMA and PVDF-HFP PBMA and PVDF-HFP PBMA and PVDF-HFP | Everolimus Everolimus Everolimus | Xience Xpedition PromusElement |
| --Stainless steel |
| SIBS | Paclitaxel | Taxus Liberte |
| --Stainless steel |
| PEVA andPBMA | Sirolimus | Cypher |
| --Co-Cr |
| MPC, LMA, HPMA, and 3-MPMA | Zotarolimus | Endeavor
|
Partiallybioresorbable Stent (PBRS-I) | Durable metal | Plain | Bioresorbable polymer | Yes |
|
| --Co-Cr --Co-Cr --Pt-Cr |
| PLLA PDLC PLGA | Novolimus Sirolimus Everolimus | DESyne Ultimaster SYNERGY |
Partially bioresorbable Stent (PBRS-II) | Durable metal | Coated | Bioresorbable polymer | Yes |
|